Clinical trial
Dopamine Transporter Scintigraphy Imaging (DAT-Imaging) in Patients With Lewy…
NCT00209456 · GE Healthcare, Industry · Completed
Key facts
| NCT number | NCT00209456 |
|---|---|
| Title | Dopamine Transporter Scintigraphy Imaging (DAT-Imaging) in Patients With Lewy Body Dementia |
| Official title | GEHC Has Decided Not to Provide This Detail But Will Rely on the Brief Title |
| Lead sponsor | GE Healthcare, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Lewy Body Dementia, Non-DLB Dementia, Alzheimer's, Vascular Dementia |
| Intervention type | Drug |
| Interventions | DatSCAN |
| Enrollment | 326 |
| Start date | Nov 1, 2003 |
| First posted | Sep 21, 2005 |
| Last update posted | May 16, 2007 |
| Countries | Germany |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: